Icon Wealth Partners, LLC Incyte Corp Transaction History

Icon Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $2,499 - $3,015	-34 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $2,161 - $2,997	34 New	34 $3,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $3,156 - $3,837	-38 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $3,555 - $4,430	38	38 $4,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Icon Wealth Partners, LLC with notifications on news.